Standard Chemotherapy Followed by Capecitabine as Prolonged Postoperative Adjuvant Treatment for Breast Cancer
Clinical trial NCT02842099 · UNKNOWN
Trial details
- NCT number
- NCT02842099
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2020-01-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.